Ignite Creation Date:
2024-10-26 @ 3:39 PM
Last Modification Date:
2024-10-26 @ 3:39 PM
Study NCT ID:
NCT06583551
Status:
COMPLETED
Last Update Posted:
None
First Post:
2024-08-29
Brief Title:
Effectiveness of Botox Dry Needling Pharmacological Treatment and Manual Therapy for Bruxism-Induced Myalgia
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Comparison of the Effectiveness of Botox Dry Needling Pharmacological Treatment and Manual Therapy for Bruxism-Induced Myalgia a Prospective Randomized Study
Status:
COMPLETED
Status Verified Date:
2021-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Eighty individuals 44 female 36 male which were randomly divided into 4 groups of 20 patients each due to the treatment type Botulinum toxin BTX Dry needling DN Pharmacological therapy PT and Manual therapy MT All treatments were carried out by the same maxillofacial surgeon An informed consent form was obtained from all participants
Detailed Description:
The study aimed to assess and compare the effectiveness of 4 different methods in the management bruxism Botulinum toxin BTX-A dry needling DN pharmacological therapy PT and manual therapy MT 80 bruxist patients 44 female 36 male were randomly divided into 4 groups of 20 patients each Botulinum toxin dry needling pharmacological therapy and manual therapy were carried out by the same maxillofacial surgeon in all patients The following measurements were recorded by another investigator in each group at baseline before treatment and at post-treatment intervals of 2nd 4th and 12th weeks Visual Analogue Scale VAS for pain maximum painless mouth opening mm Oral Health Impact Profile14 OHIP-14
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None